Image (Cyclobenzaprine HCl Tabs Structure)
Cyclobenzaprine Hydrochloride Tablet, Film Coated
Product Images NDC 67296-2084
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Cyclobenzaprine Hydrochloride (NDC 67296-2084). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Redpharm Drug, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Ndc 72888-014-00 Bottles Of 1000 Tablets (Cyclobenzaprine HCl Tabs Usp 10mg 1000s)
Ndc 72888-014-01 Bottles Of 100 Tablets (Cyclobenzaprine HCl Tabs Usp 10mg 100s)
Ndc 72888-014-05 Bottles Of 500 Tablets (Cyclobenzaprine HCl Tabs Usp 10mg 500s)
Not available.*
Ndc 72888-012-00 Bottles Of 1000 Tablets (Cyclobenzaprine HCl Tabs Usp 5mg 1000s)
Ndc 72888-012-01 Bottles Of 100 Tablets (Cyclobenzaprine HCl Tabs Usp 5mg 100s)
Ndc 72888-012-05 Bottles Of 500 Tablets (Cyclobenzaprine HCl Tabs Usp 5mg 500s)
This is a description of a medication containing 5 mg of Cyclobenzaprine hydrochloride per film-coated tablet. The tablets are dispensed in a tightly closed, light-resistant container with a child-resistant closure. The usual dosage and prescribing information can be found in the accompanying materials. It is important to keep this medication out of the reach of children and store it at a temperature between 20°C to 25°C (68°F to 77°F). The medication is distributed by Advagen Pharma Limited, located in Plainsboro, NJ, USA and manufactured by Rubicon Research Private Limited in Ambernath, Dist. Thane, India.*
Ndc 72888-013-01 Bottles Of 100 Tablets (Cyclobenzaprine HCl Tabs Usp 7 5mg 100s)
This text provides information about a medication called Cyclobenzaprine hydrochloride. It is in the form of film-coated tablets. The usual dosage and prescribing information should be consulted before use. The tablets should be dispensed in a tightly closed, light-resistant container with a child-resistant closure. The medication should be kept out of the reach of children and stored at a temperature of 20°C to 25°C (68°F to 77°F). The product contains 7.5mg of Cyclobenzaprine hydrochloride. It is available in a pack of 100 tablets. The medication is distributed by Advagen Pharma Limited, located in Plainsboro, NJ, USA, and manufactured by Rubicon Research Private Limited, located in Ambernath, India.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
